Tag: ANMAT

• Friday, April 10th 2026 - 17:54 UTC

  Argentina permanently revokes licenses of laboratories implicated in contaminated fentanyl case

  

  Argentina's National Administration of Drugs, Foods and Medical Devices (Anmat) permanently revoked the operating licenses of laboratories HLB Pharma and Laboratorios Ramallo, linked to the production of contaminated fentanyl that caused the deaths of at least 111 people between late 2024 and the first half of 2025, in one of the worst health tragedies in the country's recent history.

  Add your comment!
• Sunday, April 30th 2023 - 14:34 UTC

  Japanese vaccine against dengue approved for use in Argentina

  

  Argentine health authorities have approved the use of a Japanese vaccine against dengue that needs to be administered in two doses three months apart from one another, it was reported in Buenos Aires.

• Thursday, January 6th 2022 - 17:54 UTC

  DIY COVID-19 tests given green light in Argentina

  

  Argentina's sanitary agency ANMAT has issued the green light Wednesday to the distribution and commercialization of COVID-19 self-testing kits, as coronavirus infections soar nationwide.

• Thursday, June 10th 2021 - 08:46 UTC

  Argentina: Medical equipment donated by Lionel Messi stranded at Rosario airport for 10 months

  

  Some 32 ventilators donated by footballer Lionel Messi have been stored at his native Rosario's Fisherton international airport for 10 months, entangled in red tape.

• Wednesday, April 21st 2021 - 09:45 UTC

  First batch of Argentine-made Sputnik V vaccine delivered

  

  Argentine laboratory Richmond Tuesday delivered the first batch of locally-produced Sputnik V vaccines against covid-19 to be sent to Russia's Gamaleya Institute for final validation, it was announced.

• Thursday, December 31st 2020 - 08:50 UTC

  Argentina's regulator approves the AstraZeneca and Oxford University Covid-19 vaccine

  

  Argentina's regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.